Bestclinicabroad
Connect with the world's Best Clinic and doctors at Best Clinic Abroad. Your well-being is our priority, with personalized care every step of the way.
Connect with the world's Best Clinic and doctors at Best Clinic Abroad. Your well-being is our priority, with personalized care every step of the way.
Cancer and blood disorders remain major global health challenges. According to the World Health Organization, cancer is one of the leading causes of death worldwide, with millions of new cases diagnosed each year. Hematologic conditions such as leukemia, lymphoma, multiple myeloma, anemia, clotting disorders, and bone marrow diseases also contribute significantly to morbidity across all age groups. The growing demand for specialized cancer and blood disorder care has increased the need for experienced hematologists-oncologists working within structured, safety-focused healthcare systems.
Belgium has a nationally regulated healthcare framework supported by university hospitals, tertiary cancer centers, and multidisciplinary oncology units. Hematologists-oncologists in Belgium complete comprehensive medical education followed by specialized training in internal medicine, hematology, and medical oncology. Many are affiliated with academic institutions and participate in clinical research and tumor board discussions. Clinical practice typically follows European Society for Medical Oncology and European Hematology Association guidelines, ensuring evidence-based diagnostic and treatment pathways.
Modern hematology-oncology care in Belgium includes advanced imaging, molecular diagnostics, immunotherapy protocols, targeted therapies, chemotherapy, bone marrow transplantation programs, and supportive care services. Treatment decisions are individualized based on disease type, stage, genetic markers, and overall patient health. Multidisciplinary collaboration among oncologists, hematologists, pathologists, radiologists, surgeons, and palliative care specialists is common.
For international patients seeking hematologists-oncologists in Belgium, healthcare infrastructure is modern and regulated. Costs vary depending on treatment complexity and hospital setting. Emotional and psychological support services are often integrated into oncology programs, recognizing the personal and family impact of cancer and blood disorders. Belgium provides a structured and evidence-based environment for evaluation and management.
Martine Piccart, MD, PhD
Specialization: Medical Oncology
Years of Experience: 35+ years
Hospital: Institut Jules Bordet, Brussels
Professor Martine Piccart is a medical oncologist specializing in breast cancer management. At Institut Jules Bordet, a dedicated cancer center, she has contributed to clinical research in targeted therapies and personalized oncology. Her clinical focus includes systemic treatment planning based on tumor biology and staging. Treatment decisions are made within multidisciplinary tumor boards. Patient care emphasizes evidence-based protocols and careful monitoring of treatment-related side effects.
Michel Ducreux, MD
Specialization: Gastrointestinal Oncology
Years of Experience: 30+ years
Hospital: Cliniques Universitaires Saint-Luc, Brussels
Dr. Michel Ducreux focuses on gastrointestinal cancers, including colorectal and pancreatic malignancies. At Cliniques Universitaires Saint-Luc, he works within structured oncology pathways guided by European treatment recommendations. Management includes chemotherapy, targeted therapy, and coordination with surgical teams when appropriate. Treatment risks, such as infection and hematologic suppression, are discussed during consultation. Follow-up plans are individualized based on response and tolerance.
Frédéric Baron, MD, PhD
Specialization: Hematology and Bone Marrow Transplantation
Years of Experience: 20+ years
Hospital: University Hospital of Liège
Professor Frédéric Baron specializes in hematologic malignancies and stem cell transplantation. At the University Hospital of Liège, he participates in bone marrow transplant programs for leukemia and lymphoma. Pre-transplant evaluation includes comprehensive risk assessment and donor compatibility testing. Post-transplant monitoring addresses infection risk and graft-related complications. Care follows international hematology guidelines and structured safety protocols.
Tessa Kerre, MD, PhD
Specialization: Hematology
Years of Experience: 20+ years
Hospital: Ghent University Hospital
Professor Tessa Kerre focuses on leukemia, lymphoma, and hematopoietic stem cell transplantation. At Ghent University Hospital, she works within a multidisciplinary hematology unit. Diagnostic evaluation includes molecular testing and bone marrow biopsy when indicated. Treatment planning is individualized based on disease subtype and patient fitness. Close monitoring is essential due to potential treatment-related complications.
Ahmad Awada, MD, PhD
Specialization: Medical Oncology
Years of Experience: 25+ years
Hospital: Institut Jules Bordet, Brussels
Dr. Ahmad Awada specializes in solid tumor oncology, including breast and gastrointestinal cancers. At Institut Jules Bordet, he contributes to systemic therapy planning and clinical trial participation. Treatment decisions are based on tumor staging, pathology findings, and patient health status. Side effect management and supportive care are integral to treatment pathways. Patients are informed about the potential risks and limitations of therapy.
Dominique Bron, MD, PhD
Specialization: Hematology
Years of Experience: 30+ years
Hospital: Cliniques Universitaires Saint-Luc, Brussels
Professor Dominique Bron focuses on chronic leukemias and myeloproliferative disorders. At Cliniques Universitaires Saint-Luc, she participates in structured hematology programs. Diagnostic evaluation includes laboratory analysis and bone marrow examination. Treatment may involve targeted therapies or immunomodulatory agents when clinically appropriate. Long-term monitoring is essential due to disease variability.
Jan Cools, MD, PhD
Specialization: Hematologic Malignancies and Molecular Hematology
Years of Experience: 20+ years
Hospital: University Hospitals Leuven (UZ Leuven)
Professor Jan Cools specializes in molecular mechanisms of leukemia and targeted treatment strategies. At UZ Leuven, he collaborates with clinical hematology teams in translational research and patient care. Diagnostic work includes genetic profiling to guide therapy selection. Treatment plans are individualized based on mutation status and clinical condition. Ongoing follow-up is important to monitor disease response.
Philippe Noens, MD
Specialization: Hematology
Years of Experience: 25+ years
Hospital: Antwerp University Hospital
Dr. Philippe Noens focuses on chronic myeloid leukemia and other hematologic disorders. At Antwerp University Hospital, he contributes to guideline-based management of blood cancers. Diagnostic assessment includes cytogenetic and molecular testing. Treatment selection depends on disease phase and patient tolerance. Regular monitoring is necessary to assess treatment effectiveness and side effects.
The specialists listed above are provided for informational purposes only and do not represent rankings or endorsements.
| Consultation Type | Estimated Cost Range |
| Hematologists-Oncologists consultation | $200–$500 |
Note: Costs are approximate and provided for general guidance only. Prices vary depending on the healthcare provider, hospital type, city, and consultation format (in-person or remote). Diagnostic tests, imaging, or additional evaluations are not included. Final fees are determined by the provider after an individual clinical assessment and may be affected by currency fluctuations.
Choosing a hematologist-oncologist in another country can feel overwhelming. Cancer and blood disorders require careful evaluation, and you may have concerns about safety, communication, and treatment coordination. Understanding how a healthcare system operates can help you make informed decisions.
➤ Availability of English-speaking medical staff and professional medical translators in many facilities
➤ Specialized clinics that manage a high volume of international patients
➤ Government regulations and oversight mechanisms supporting medical tourism safety and international patient protection
➤ Structured hospital documentation, patient-safety protocols, and informed consent practices
For international patients, practical factors should be reviewed carefully. Visa or entry requirements depend on your nationality and the expected duration of stay. For chemotherapy cycles, transplantation, or complex cancer treatment, a stay of at least 7–14 days or longer may be necessary, depending on the treatment schedule. In major cities such as Brussels, Leuven, Ghent, and Antwerp, multilingual services are common, but language barriers may arise in smaller regions. Planning follow-up care with your local oncologist or hematologist after returning home is essential for monitoring treatment response and managing potential side effects.
Patients considering Hematologists-Oncologists care in Belgium can share their medical reports, pathology findings, and imaging studies with Best Clinic Abroad to receive coordinated guidance on consultation options and structured support for treatment planning.
Do I need a medical visa to travel to Belgium for cancer or blood disorder treatment?
Visa requirements depend on your nationality and the expected length of treatment. Many non-European patients require a Schengen visa for medical travel. You should contact the Belgian embassy or consulate in your country for accurate information. Hospitals may provide documentation confirming your appointment, but visa approval is determined by immigration authorities.
Can I communicate in English with hematologists-oncologists in Belgium?
In most university hospitals and cancer centers, hematologists-oncologists and clinical teams speak English. International patient departments often assist with coordination and documentation. However, language availability may vary outside large cities. Interpreter services can usually be arranged in advance to support clear communication.
Is it possible to arrange an online consultation before traveling for hematology or oncology treatment?
Yes, you can request an online consultation through Best Clinic Abroad. You may securely share pathology reports, imaging results, and laboratory findings for preliminary review. This helps you understand potential treatment pathways and whether in-person evaluation in Belgium is appropriate. Final treatment decisions are made only after a comprehensive clinical assessment.
How long should I plan to stay in Belgium for cancer treatment?
The duration of stay depends on the type of cancer and treatment plan. Chemotherapy cycles, immunotherapy sessions, or stem cell transplantation may require repeated visits or extended stays. Your treating team will provide individualized guidance based on your treatment schedule and clinical condition.
What happens with follow-up care after I return home?
Follow-up care is essential in oncology and hematology. Before returning home, you should obtain detailed medical summaries, treatment protocols, and medication instructions. Coordination with your local oncologist ensures continuity of care and ongoing monitoring. Clear communication between healthcare teams supports long-term safety.
Disclaimer
This content is provided for informational purposes only and does not constitute medical advice. Diagnosis and treatment decisions should be made in consultation with a licensed medical specialist based on individual clinical evaluation.
